Roche, the Accutane manufacturer, told Judge Johnson that plantiffs’ experts ignored several recent studies disputing an association with Accutane and Crohn's disease (an inflammatory bowel disorder, or IBD), calling their testimony “a war against science.” Roche argued that plaintiffs’ gastroenterology expert Arthur Kornbluth relied on flawed methodology and ignored nine epidemiological studies from the past five years that did not find a link between Accutane and the inflammatory bowel condition.
Currently, about 6,700 Accutane lawsuits claim the acne medication causes bowel disorders.
READ MORE ACCUTANE IBD LEGAL NEWS
It is expected in this current litigation that Judge Johnson will determine whether Accutane’s warnings after 2002 were adequate. Oral arguments regarding the warnings are scheduled to take place in mid-March.
The consolidated litigation is In re: Accutane Litigation, case number 271, in the Superior Court of New Jersey in Atlantic County.